Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C16H14N2O4S |
| Molecular Weight | 330.358 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NS(=O)(=O)C1=CC=C(C=C1)C2=C(CO)ON=C2C3=CC=CC=C3
InChI
InChIKey=UJSFKTUZOASIPA-UHFFFAOYSA-N
InChI=1S/C16H14N2O4S/c17-23(20,21)13-8-6-11(7-9-13)15-14(10-19)22-18-16(15)12-4-2-1-3-5-12/h1-9,19H,10H2,(H2,17,20,21)
| Molecular Formula | C16H14N2O4S |
| Molecular Weight | 330.358 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 11:13:52 UTC 2023
by
admin
on
Sat Dec 16 11:13:52 UTC 2023
|
| Record UNII |
T5Q8Y8772I
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
9818888
Created by
admin on Sat Dec 16 11:13:53 UTC 2023 , Edited by admin on Sat Dec 16 11:13:53 UTC 2023
|
PRIMARY | |||
|
181695-81-8
Created by
admin on Sat Dec 16 11:13:53 UTC 2023 , Edited by admin on Sat Dec 16 11:13:53 UTC 2023
|
PRIMARY | |||
|
DTXSID30431308
Created by
admin on Sat Dec 16 11:13:53 UTC 2023 , Edited by admin on Sat Dec 16 11:13:53 UTC 2023
|
PRIMARY | |||
|
T5Q8Y8772I
Created by
admin on Sat Dec 16 11:13:53 UTC 2023 , Edited by admin on Sat Dec 16 11:13:53 UTC 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> METABOLITE ACTIVE |
MINOR
URINE
|
||
|
PARENT -> METABOLITE ACTIVE |
Plasma concentrations of valdecoxib were 10-20 fold higher than the corresponding SC-66905 (M1) concentrations. The metabolite M1 is a less potent COX-2 specific inhibitor than the parent.
MAJOR
PLASMA
|
||
|
PARENT -> METABOLITE ACTIVE |
FECAL
|
